Reumatismo (Sep 2011)
Sustained response to infliximab treatment in two cases of early rheumatoid arthritis that has been maintained after drug withdrawal
Abstract
The authors report two cases of active seropositive rheumatoid arthritis who were treated in an early phase of the disease with infliximab plus methotrexate obtaining a clinical remission. The benefit was maintained after the discontinuation of the anti-TNF alpha inhibitor for adverse events, indicating that the early administration of the drug may be followed by a sustained remission.